24 April 2020

In this paper, the authors discuss their consensus recommendations pertaining to the care of muscular dystrophy patients during the COVID-19 pandemic, in particular:

  • Corticosteroid and exon skipping treatments
  • Cardiac medications
  • Hydroxychloroquine use
  • Emergency and respiratory care
  • Rehabilitation management
  • Conduct of clinical trials

 

The importance of collaborative treatment decisions between the patient, family, and health care provider, considering any geographic or institution‐specific policies and precautions for COVID‐19 is highlighted, with the authors advocating for continued multidisciplinary care for these patients using telehealth.

To read the full article: https://onlinelibrary.wiley.com/doi/epdf/10.1002/mus.26902